IMPERFECT OSTEOGENESIS AS A DIFFERENTIAL DIAGNOSIS OF SECONDARY OSTEOPOROSIS
Keywords:
Osteogenesis imperfecta, Secondary osteoporosis, Recurrent fracturesAbstract
Introduction: Osteogenesis imperfecta (OI) is a rare genetic disorder of connective tissue, resulting from mutations in the genes responsible for the synthesis or structure of type I collagen. Characterized by variable bone fragility, it can lead to frequent fractures even after minimal trauma. There are five main types of OI, varying in severity due to different genetic mutations. Objective: To describe a clinical case of type IV osteogenesis imperfecta (OI), highlighting the importance of the differential diagnosis with secondary osteoporosis and discussing the currently available therapeutic approaches. Case Report: Female patient with a history of recurrent fractures since early childhood, short stature, bone deformities, grayish sclerae, and progressive bilateral hearing loss. The patient was referred to the outpatient clinic for osteometabolic diseases for investigation of bone fragility. Genetic testing identified a mutation in the COL1A1 gene, confirming the diagnosis of type IV OI. Treatment included intravenous bisphosphonates, regular physiotherapy rehabilitation, and corrective orthopedic surgeries, with progressive improvement in functional status. The patient remains under multidisciplinary follow-up, focusing on fracture prevention, promotion of functional independence, and psychosocial support. Conclusion: This case reinforces the importance of considering OI in the differential diagnosis of patients with recurrent fractures and highlights the role of continuous multidisciplinary follow-up in the clinical management of the disease. Early diagnosis allows for better therapeutic planning and appropriate genetic counseling.
References
ALENIZI, M.M. et al. Complications among patients with osteogenesis imperfecta following surgical interventions. Journal of musculoskeletal surgery and research, v.7, p.265–270, 2023.
ALRASBI, A.A. et al. Outcomes of modified Sofield procedure in children with osteogenesis imperfecta in Oman. Journal of Musculoskeletal Surgery and Research, v. 6, p.219–225, 2022.
Brasília: Ministério da Saúde, 2022. BRASIL. Protocolo Clínico e Diretrizes Terapêuticas para Osteogênese Imperfeita. Brasília: Ministério da Saúde, 2022.
DAMIAN, L.O. et al. Osteogenesis imperfecta and rheumatoid arthritis: is there a link?. Archives Of Osteoporosis, v. 15, n. 1, 2020.
DAVID, V.E., et al. Uma abordagem geral da Osteogênese imperfeita. Revista Eletrônica Acervo Médico, v.23, n. 3, p.e12125–e12125, 2023.
EL-GAZZAR, A., HOGLER, W. Mechanisms of Bone Fragility: from osteogenesis imperfecta to secondary osteoporosis. International Journal Of Molecular Sciences, v. 22, n. 2, p. 625-633, 2021.
FRANZONE, J.M. et al. Osteogenesis Imperfecta. Orthopedic Clinics of North America,v. 50, n. 2, p. 193-209, 2019.
FOTIADOU, N.A. et al. Skeletal Manifestations of Osteogenesis Imperfecta. Seminars in Musculoskeletal Radiology, v. 20, n. 3, p. 279-286, 2016.
JOVANOVIC, M. et al. Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types. Endocr Rev, v. 43, n. 1, p. 61-90, 2021.
KAISSI, A.A. et al. How frequent is osteogenesis imperfecta in patients with idiopathic osteoporosis? Medicine, v. 96, n. 35, 2017.
LAINE, C.M. et al. WNT1 Mutations in Early-Onset Osteoporosis and Osteogenesis Imperfecta. New England Journal Of Medicine, v. 368, n. 19, p. 1809-1816, 2013.
LIU, W. et al. Approach to the Patient: pharmacological therapies for fracture risk reduction in adults with osteogenesis imperfecta. The Journal Of Clinical Endocrinology & Metabolism, v. 108, n. 7, p. 1787-1796, 2023.
LUDWIG, K. et al. Dominant osteogenesis imperfecta with low bone turnover caused by a heterozygous SP7 variant. Bone, v. 160, 2022.
MAROM, R. et al. Osteogenesis imperfecta: an update on clinical features and therapies. European Journal of Endocrinology, v. 183, n. 4, p. 95-106, 2020.
PADUANO, F. et al. Expanding the genetic and clinical spectrum of osteogenesis imperfecta: identification of novel rare pathogenic variants in type I collagen-encoding genes. Front Endocrinol, v. 14, 2023.
PAIVA, D.F. et al. Percepções de pessoas com osteogênese imperfeita acerca das intervenções terapêuticas ocupacionais e possibilidades de cuidado. Cad. Bras. Ter. Ocup, v.26, n. 2, p. 399-407, 2018.
TAUSEEF, U. et al. Osteogenesis Imperfecta-Serine Replacing Glycine in the COL1A1 Gene-A New Establishment in Genetics. Fortune Journal of Rheumatology, v. 2, n. 2, 2020.